Adriana Karaboutis - Perrigo Company Independent Director

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 35px;;'>PRG</div>
PRGO -- USA Stock  

Last Earning Anouncement Date: December 31, 2015  

  Director
Ms. Adriana Karaboutis is Independent Director at Perrigo Company Public Limited Company. Since August 2017, Ms. Karaboutis has served as Chief Information and Digital Officer of National Grid, a publicly traded utility company. Ms. Karaboutis served as Executive Vice President, Technology, Business Solutions and Corporationrationrate Affairs at Biogen Inc., an independent biotechnology company from December 2015 to February 2017, and as Executive Vice President, Technology and Business Solutions from September 2014 to December 2015. Prior to that, Ms. Karaboutis served as Vice President and Global Chief Information Officer of Dell, Inc., a global technology company, from 2011 to September 2014, and as Vice President of IT, Global Operations and Technology from 2010 to 2011. Ms. Karaboutis spent more than 20 years at General Motors Corporationrationration and Ford Motor Company in various leadership positions, including computerintegrated manufacturing, supply chain operations and information technology. In addition, Ms. Karaboutis was a director of Advance Auto Parts, Inc. since 2015. Ms. Karaboutis served on the board of directors of Blue Cross Blue Shield of Massachusetts from February 2016 to December 2017.
Age: 55  Director Since 2017      
353 1 709 4000  http://www.perrigo.com
Karaboutis spent more than 20 years at General Motors Corporationrationrationration and Ford Motor Company in various leadership positions, including computerintegrated manufacturing, supply chain operations and information technology. In addition, Ms. Karaboutis was a director of Advance Auto Parts, Inc. since 2015 and Blue Cross Blue Shield of Massachusetts since 2016.

Management Efficiency

The company has return on total asset (ROA) of 2.19 % which means that it generated profit of $2.19 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 4.32 % meaning that it created $4.32 on every $100 dollars invested by stockholders.
The company currently holds 3.5 B in liabilities with Debt to Equity (D/E) ratio of 60.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 2.03 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Yuchun LeeVertex Pharmaceuticals Incorpor
2012
J MoreauDr Reddys Laboratories Ltd
2007
Leo PuriDr Reddys Laboratories Ltd
2018
Lloyd CarneyVertex Pharmaceuticals Incorpor
2019
Prasad MenonDr Reddys Laboratories Ltd
2019
Allan ObermanDr Reddys Laboratories Ltd
2019
Anupam PuriDr Reddys Laboratories Ltd
2002
Linda RhodesZoetis
2017
Bharat DoshiDr Reddys Laboratories Ltd
2016
Paul BisaroZoetis
2015
Fei WangOrigin Agritech Limited
2019
George SingRegeneron Pharmaceuticals
1988
Bruce CarterDr Reddys Laboratories Ltd
2008
Ravi BhoothalingamDr Reddys Laboratories Ltd
2000
Michael BrownRegeneron Pharmaceuticals
1991
Bonnie BasslerRegeneron Pharmaceuticals
2016
Larry CordellOrigin Agritech Limited
2012
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011
Michael TrimbleOrigin Agritech Limited
2006
Yingqi XiaOrigin Agritech Limited
2010

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Did you try this?

Run Portfolio Holdings Now

   

Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module

Currently Active Assets on Macroaxis

C   
Purchased over 30 shares of
few hours ago
Traded for 80.1
F   
Purchased over 300 shares of
few hours ago
Traded for 9.16
CRSP   
Purchased over 50 shares of
few hours ago
Traded for 58.39
GM   
Purchased over 70 shares of
few hours ago
Traded for 34.91
S   
Purchased over 500 shares of
few hours ago
Traded for 5.02
Please also check Your Equity Center. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.